Exane Derivatives’s Dentsply Sirona XRAY Stock Holding History

Exane Derivatives’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-688	Closed	-$39.9K	–	1079
2021 Q3	$39.9K	Buy	+688	New	+$42.4K	0.01%	641

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Exane Derivatives's XRAY Position: Q4 2021 in Review

Exane Derivatives sold out of Dentsply Sirona (XRAY) in Q4 2021, closing a stake of 688 shares — an estimated $39.9K sold.

Exane Derivatives first reported a position in XRAY in Q3 2021 and held it in 1 quarter. The position peaked at $39.9K in Q3 2021. 542 funds tracked by Wall St. Rank hold XRAY as of Q4 2021.

Exane Derivatives reported no remaining Dentsply Sirona position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 688 Dentsply Sirona shares in Q4 2021, an estimated $39.9K.
Exane Derivatives first reported a position in Dentsply Sirona in Q3 2021 and held it in 1 quarter.
Exane Derivatives's Dentsply Sirona position peaked at $39.9K in Q3 2021.
542 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.